Autoantibodies in post-treatment Lyme disease syndrome

Front Neurol. 2022 Sep 1:13:1004853. doi: 10.3389/fneur.2022.1004853. eCollection 2022.

Armin Alaedini^{1

2

3}, Gary P Wormser³

¹ Department of Medicine, Columbia University, New York, NY, United States.
² Institute of Human Nutrition, Columbia University, New York, NY, United States.
³ Division of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, NY, United States.

No abstract available

Keywords: Borrelia burgdorferi; COVID-19; Lyme disease; autoantibody; immunoassay; infection; inflammation; post-treatment Lyme disease syndrome.